Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry‐based assay for serum apolipoproteins coupled to multi‐marker ROC algorithm

No abstract is available for this paper.

• Publication year

  2012

• Venue

  PROTEOMICS - Clinical Applications

• Publication date

  2012-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/prca.201100041PMID 22532455PMCID PMC3910141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.

  2013cited by this paper
• Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.

  2011influential reference
• Evaluation of absolute peptide quantitation strategies using selected reaction monitoring

  2011cited by this paper
• Discriminative capacity of biomarkers for acute stroke in the emergency department.

  2011cited by this paper
• Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays.

  2010influential reference
• HDL in humans with cardiovascular disease exhibits a proteomic signature.

  2010cited by this paper
• Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry

  2010cited by this paper
• The challenge of mixed cerebrovascular disease

  2010cited by this paper
• Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins

  2010cited by this paper
• Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants.

  2010cited by this paper
• Full-length characterization of proteins in human populations.

  2010cited by this paper
• Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry.

  2010cited by this paper
• Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors

  2010cited by this paper
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma*

  2009cited by this paper
• Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review.

  2009cited by this paper
• Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) Study

  2009cited by this paper
• Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated?

  2009cited by this paper
• Reperfusion injury after stroke: neurovascular proteases and the blood-brain barrier.

  2009cited by this paper
• Apolipoprotein CIII links dyslipidemia with atherosclerosis.

  2009cited by this paper
• Invited Article: Searching for oracles?

  2009cited by this paper
• Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

  2009cited by this paper
• Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

  2009cited by this paper
• Vascular risk factors, cognitve decline, and dementia

  2008cited by this paper
• Selected reaction monitoring for quantitative proteomics: a tutorial

  2008cited by this paper
• An ABC of apolipoprotein C‐III: a clinically useful new cardiovascular risk factor?

  2008cited by this paper
• Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.

  2008cited by this paper
• Metabolic syndrome--risk factors for atherosclerosis and diabetes.

  2008cited by this paper
• Performance characteristics of an FT MS‐based workflow for label‐free differential MS analysis of human plasma: standards, reproducibility, targeted feature investigation, and application to a model of controlled myocardial infarction

  2008cited by this paper
• Semi-supervised learning for peptide identification from shotgun proteomics datasets

  2007cited by this paper
• Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome

  2007cited by this paper
• Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins*

  2006cited by this paper
• ApoC‐I and ApoC‐III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke

  2004cited by this paper
• The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

  2004cited by this paper
• The apoAI-CIII-AIV gene cluster.

  2001cited by this paper
• Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

  2001cited by this paper
• Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Vascular Health and Risk Management Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Lipoprotein Ratios: Physiological Significance and Clinical Usefulness in Cardiovascular Prevention

  year unknowncited by this paper

• Apolipoproteins in circulation: At the interface of thrombosis and stroke initiation.

  2025cites this paper
• Comprehensive transcriptomic analysis integrating bulk and single-cell RNA-seq with machine learning to identify and validate mitochondrial unfolded protein response biomarkers in patients with ischemic stroke

  2025cites this paper
• Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged

  2024cites this paper
• Subtyping strokes using blood-based biomarkers: A proteomics approach

  2023influential citation
• Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications.

  2022cites this paper
• Detection, Diagnosis and Treatment of Acute Ischemic Stroke: Current and Future Perspectives

  2022cites this paper
• Computed tomography angiography versus ultrasound in patients with ischemic stroke owing to carotid artery disease

  2022cites this paper
• Blood-based protein biomarkers for the diagnosis of acute stroke: A discovery-based SWATH-MS proteomic approach

  2022cites this paper
• Multi-omics research strategies in ischemic stroke: A multidimensional perspective.

  2022cites this paper
• Fenamates as Potential Therapeutics for Neurodegenerative Disorders

  2021cites this paper
• Angiogenesis Biomarkers in Ischemic Stroke Patients

  2021cites this paper
• Timely and Blood-Based Multiplex Molecular Profiling of Acute Stroke

  2021cites this paper
• Acute Stroke Biomarkers: Are We There Yet?

  2021cites this paper
• Investigating the Role of VGF and Its Associated Neuropeptides in Post-Stroke Recovery and Repair

  2020cites this paper
• Stroke Biomarkers

  2020influential citation
• Blood Biomarkers for Stroke Differentiation

  2019cites this paper
• Serum Proteome Alterations in Human Cystathionine β-Synthase Deficiency and Ischemic Stroke Subtypes

  2019cites this paper
• Examining the Effects of Pause Times on Auditory Comprehension Utilizing Secondary Data Analysis

  2019cites this paper
• Identification Customer Need for Redesign Feet and Hands Strength Training Equipment for the Post-Ischemic Stroke Patients

  2019cites this paper
• Proteomic Analysis of Cerebral Cortex Extracts from Sus scrofa with Induced Hemorrhagic Stroke

  2018cites this paper
• Changes in the Hippocampal Proteome Associated with Spatial Memory Impairment after Exposure to Low (20 cGy) Doses of 1 GeV/n 56Fe Radiation

  2017cites this paper
• Quantitative Proteomic Analysis of the Hippocampus of Rats with GCR-Induced Spatial Memory Impairment

  2017cites this paper
• Blood microRNAs as potential diagnostic markers for hemorrhagic stroke

  2017cites this paper
• Molecular Links and Biomarkers of Stroke, Vascular Dementia, and Alzheimer's Disease.

  2017cites this paper
• Blood‐based protein biomarkers for stroke differentiation: A systematic review

  2017cites this paper
• Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics

  2017cites this paper
• Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.

  2016cites this paper
• Predicting the outcomes for out-of-hospital cardiac arrest patients using multiple biomarkers and suspension microarray assays

  2016cites this paper
• Peripheral biomarkers of stroke: Focus on circulatory microRNAs.

  2016cites this paper
• A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression – A Pilot Study

  2016cites this paper
• Unbiased and targeted mass spectrometry for the HDL proteome

  2016cites this paper
• Practical, Broadly Applicable Workflow for Rapid Development of MS-based SRM Methods for Translational Research

  2015cites this paper
• Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis

  2014cites this paper
• The role of apolipoprotein E in neurodegeneration and cardiovascular disease

  2014cites this paper
• Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues.

  2013cites this paper
• Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.

  2013cites this paper
• Depletion of nuclear histone H2A variants is associated with chronic DNA damage signaling upon drug-evoked senescence of human somatic cells

  2012cites this paper
• Heart-Brain Signaling in Patent Foramen Ovale–Related Stroke

  2012cites this paper
• Application of proteomics to cerebrovascular disease

  2012cites this paper
• Role of Genetic Polymorphism in the Pathogenesis of Cerebrovascular Disease

  2012cites this paper
• Proteomics-Based Biomarker Discovery Study in Human and non-Human Plasma Using a Two-Pass Workflow

  2012cites this paper
• OMICs in Stroke

  year unknowncites this paper